SEC Form 4 · accession 0001144204-15-037758
Pulmatrix, Inc. · PULM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David L. Hava
Officer — Chief Scientific Officer
Period of report
Jun 15, 2015
Accepted (ET)
Jun 17, 2015 · 8:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574235
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 15, 2015 | A | 4,863 | — | A | 4,863 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3,F4,F1 | $2.20 | Jun 15, 2015 | A | 3,555 | A | — | Feb 10, 2020 | Common Stock | 3,555 | 3,555 | D |
| Stock Option (Right to Buy)F5,F4,F1 | $2.20 | Jun 15, 2015 | A | 804 | A | — | May 24, 2020 | Common Stock | 804 | 804 | D |
| Stock Option (Right to Buy)F6,F7,F1 | $2.20 | Jun 15, 2015 | A | 2,668 | A | — | Feb 3, 2021 | Common Stock | 2,668 | 2,668 | D |
| Stock Option (Right to Buy)F8,F7,F1 | $2.20 | Jun 15, 2015 | A | 2,964 | A | — | Jun 15, 2021 | Common Stock | 2,964 | 2,964 | D |
| Stock Option (Right to Buy)F9,F7,F1 | $2.03 | Jun 15, 2015 | A | 5,928 | A | — | Jun 8, 2022 | Common Stock | 5,928 | 5,928 | D |
| Stock Option (Right to Buy)F10,F4,F1 | $2.03 | Jun 15, 2015 | A | 11,855 | A | — | Jun 8, 2022 | Common Stock | 11,855 | 11,855 | D |
| Stock Option (Right to Buy)F11,F7,F1 | $2.03 | Jun 15, 2015 | A | 13,041 | A | — | Dec 14, 2022 | Common Stock | 13,041 | 13,041 | D |
| Stock Option (Right to Buy)F12,F13,F1 | $1.88 | Jun 15, 2015 | A | 14,819 | A | — | Aug 26, 2023 | Common Stock | 14,819 | 14,819 | D |
| Stock Option (Right to Buy)F14,F1 | $11.80 | Jun 16, 2015 | A | 267,129 | A | — | Jun 16, 2025 | Common Stock | 267,129 | 267,129 | D |
Explanation of responses
- F1Reflects a 1-for-2.5 reverse stock split effected on June 15, 2015.
- F10These securities were received in the Merger in exchange for a stock option to acquire 200,000 shares for $0.12 per share of common stock of the Former Entity.
- F11These securities were received in the Merger in exchange for a stock option to acquire 220,000 shares for $0.12 per share of common stock of the Former Entity.
- F12These securities were received in the Merger in exchange for a stock option to acquire 250,000 shares for $0.11 per share of common stock of the Former Entity.
- F13These options vested/vest over a four-year period, with 50% vesting on the first anniversary of the initial date of grant by the Former Entity and 4.167% vesting each month thereafter for twelve months.
- F14The option vests as to 2.08% monthly for 48 months from the date of grant.
- F2On June 15, 2015, the Reporting Person received these shares of the Issuer's Common Stock in exchange for securities of a private company formerly known as Pulmatrix, Inc. (the "Former Entity") in connection with the merger of the Former Entity into the Issuer (the "Merger").
- F3These securities were received in the Merger in exchange for a stock option to acquire 59,965 shares for $0.13 per share of common stock of the Former Entity.
- F4These options are fully vested and exercisable.
- F5These securities were received in the Merger in exchange for a stock option to acquire 13,566 shares for $0.13 per share of common stock of the Former Entity.
- F6These securities were received in the Merger in exchange for a stock option to acquire 45,000 shares for $0.13 per share of common stock of the Former Entity.
- F7These options vested/vest over a four-year period, with 25% vesting on the first anniversary of the initial date of grant by the Former Entity and 2.083% vesting each month thereafter for thirty-six months.
- F8These securities were received in the Merger in exchange for a stock option to acquire 50,000 shares for $0.13 per share of common stock of the Former Entity.
- F9These securities were received in the Merger in exchange for a stock option to acquire 100,000 shares for $0.12 per share of common stock of the Former Entity.